‘A Political Gimmick’: Expert on China's Row With Pfizer
A highly anticipated COVID-19 drug from the United States is coming away empty-handed from sales talks with virus-hit China. Chinese officials say the American firm that makes it was charging too much....
Read More
Views expressed in this video are opinions of the host and the guest(s), and do not necessarily reflect the views of NTD.